Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 16.99

From 52W high−28.57%

Volume4.80M

Market capCNY 4.02B

P/E (TTM)30.4x

P/S (TTM)1.4x

Div yield0.94%

Key dataSep 18, 2026

Open

CNY 16.99

From 52W high

−28.57%

Volume

4.80M

Market cap

CNY 4.02B

ValuationView details →

P/E (Fwd)

22.7x

EV/EBITDA

16.4x

P/E (TTM)

30.4x

RSI (14)

49.6

MomentumView details →

1D Return

−3.65%

YTD Return

—

ValuationView details →

P/E (Fwd)

22.7x

P/E (TTM)

30.4x

EV/EBITDA

16.4x

EV/Sales

1.9x

P/S (TTM)

1.4x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

20.48%

Net Margin

4.19%

EBITDA Margin

11.90%

ROE (TTM)

4.59%

ROA (TTM)

2.05%

Asset Turnover

0.50x

GrowthView details →

Revenue YoY

+24.61%

EPS YoY

−23.94%

FCF YoY

−20.53%

Revenue CAGR 3Y

+26.35%

EPS CAGR 3Y

−36.19%

EBITDA YoY

—

MomentumView details →

1D Return

−3.65%

YTD Return

—

1Y Return

—

RSI (14)

49.6

vs 50D SMA

+0.82%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.72x

Current Ratio

1.21x

Quick Ratio

0.77x

Div Yield

0.94%

Div Rate

CNY 0.16

Div Growth 1Y

−36.00%

EarningsView details →

EPS (Actual)

CNY 0.24

EPS Surprise

−3.15%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.38

Avg Surprise (4Q)

−3.15%

Rev Surprise

−1.08%

Financials snapshotView financials →

Revenue (TTM)

2.95B

Net Income (TTM)

123.41M

Op. CF (TTM)

101.90M

Next earningsOct 22, 2026 →

Latest newsMore news →

Huaheng Biology's actual controller Guo Henghua was approved for arrest by the procuratorate on suspicion of illegally absorbing public deposits; the company received notice from her family on July 31, 2026.51d ago

Huafeng Biology terminated its H-share listing plan on the Hong Kong Stock Exchange after Guo Henghua's detention.80d ago

Similar companies

TransThera Sciences (Nanjing) Inc.02617.HK AbCellera Biologics Inc.ABCL Celcuity Inc.CELC Relay Therapeutics, Inc.RLAY Amylyx Pharmaceuticals, Inc.AMLX Ocumension Therapeutics01477.HK Find similar companies →

Latest newsMore news →

Huaheng Biology's actual controller Guo Henghua was approved for arrest by the procuratorate on suspicion of illegally absorbing public deposits; the company received notice from her family on July 31, 2026.51d ago Huafeng Biology terminated its H-share listing plan on the Hong Kong Stock Exchange after Guo Henghua's detention.80d ago Guo Henghua resigned from all positions including chairman and general manager of Huafeng Biology following her criminal detention.80d ago